1,4-Bis(4-guanylphenylethyl)benzenes as potential antitrypanosomal agents

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Parasitology

Background:

• Trypanosomiasis is a significant neglected tropical disease.
• Development of novel antitrypanosomal agents is crucial for treatment.
• Diamidine scaffolds have shown promise in antiparasitic drug discovery.

Purpose of the Study:

• To synthesize and evaluate a series of 1,4-bis(4-guanylphenylethyl)benzenes, including masked amidines.
• To screen these compounds for activity against Trypanosoma rhodesiense.
• To explore structure-activity relationships of novel diamidine derivatives.

Main Methods:

• Synthesis of 1,4-bis(4-cyanophenylethyl)benzene via diimide reduction of 1,4-bis(4-cyanostyryl)benzene.
• Preparation of diamidines from the corresponding dinitriles using standard chemical methods.
• Wittig reaction employed for the synthesis of the styryl intermediate.
• In vivo antitrypanosomal screening against Trypanosoma rhodesiense in a mouse model.

Main Results:

• A series of novel diamidine compounds were successfully synthesized.
• Several compounds exhibited significant antitrypanosomal activity against Trypanosoma rhodesiense in vivo.
• The synthetic route provided access to diverse diamidine structures for further investigation.

Conclusions:

• The synthesized diamidines represent a promising class of compounds for the development of new antitrypanosomal drugs.
• Further optimization of the lead compounds could lead to potent therapeutic agents.
• The study validates the diamidine scaffold as a viable strategy for targeting Trypanosoma rhodesiense infections.